The first steps in cell line development are the key for the success of the whole project

UGA Biopharma is a Germany-based, full contract service R&D provider in the field of mammalian cell line development. UGA`s proven core expertise is the development of cell lines for biosimilar and biotherapeutic manufacturing. The UGA offering includes:


  • Cell line development of research cell banks for pharmaceutical manufacturing (different CHO host cell lines available)
  • Upstream process development (USP) and downstream process development (DSP)
  • Contract analytical service
  • Tech transfer and process implementation consulting
  • Training in cell line development and culture techniques


  • Ready-to-use research cell banks for biosimilar manufacturing including fermentation, DSP and analytical-method protocols
  • Cost-effective and GMP-compliant cell-culture basal media for high yields (chemically defined, suitable for biopharma production) - free test sample available; feed A and B in development, launch expected in Q3/2017
  • CHO mock cell lines available for out-licensing


12/2017: Four projects successfully completed in Q4
Laronidase, Ipilimumab, Natalizumab, Pembrolizumab.   These 4 cell line development projects were successfully more

11/2017: New CEO
UGA Biopharma announces that Dr. Lars Kober, who was holding Operational Management for many years took over the management of UGA. more

10/2017: Abzena and UGA Biopharma collaborate to treat MS
See our latest press release using that more

09/2017: First CHOice - product promotion in transkript Vol 9
See the current product promotion for our High-Performance Cell Culture Medium First CHOice® published in transkript journal Vol. 9 page 41 via this more

08/2017: Collaboration between Batavia Biosciences and UGA Biopharma
Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing more

07/2017: Meet us at "New & Emerging Technologies" in Potsdam
You can meet us at the congress "New & Emerging more

05/2017: UGA Biopharma presented at BIONNALE 2017
Pitch presentation "Cell lines for biosimilar and NBE manufacturing + services" more

04/2017: Opening of additional development labs at UGA Biopharma
UGA Biopharma will open additional laboratories featuring state-of-the-art equipment at the Hennigsdorf site for cell line development and analytical contract services. The extension is tailor-made more

03/2017: Launch of UGA´s "high-speed workflow"
UGA has launched an improved cell-line-development workflow ("high-speed workflow"), which guarantees cell line development on a shortened time more

Contact us!

UGA Biopharma GmbH
16761 Hennigsdorf, Neuendorfstraße 20a (Germany)
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49 (0)3302 / 2024900